Immutep Ltd has released a press release.
Immutep Global Webcast Slides to Discuss Clinical Results
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Immutep
- Immutep announces publication of SITC 2021 posters
- Immutep announces publication of SITC 2021 abstracts
- Immutep granted Chinese Patent for eftilagimod alpha
- Immutep receives EMA scientific advice for Phase 3 in MBC
- Immutep Quarterly Activities Report & Appendix 4C
Later from Immutep
- Phase II TACTI-002 trial recruitment successfully completed
- Good safety reported from 1st five patients in INSIGHT-003
- Immutep Advances IMP761 Manufacturing
- Australian Patent Granted for Efti with PD-1 Inhibitors
- Immutep receives FDA feedback for Efti development in MBC
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep